Since NF-κB inhibitors have been tested in mdx mice as well as in DMD boys [38,39,40] and based on the beneficial effects of flavocoxid in the murine model of DMD, even higher than steroids, as reported by our group [28], we planned a phase 1/2 study. This evidence concerns the gene NFKB1 and Duchenne muscular dystrophy.